Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumin Hu

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Theranostics|July 9, 2019
Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modificationTian Tian, Jiajun Li, Yizhuo Li, et al.
Cell Research|August 31, 2011
K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysisYumin Hu, Weiqin Lu, Gang Chen, et al.
Molecular Metabolism|March 6, 2021
Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodelingXin You, Jingyu Tian, Hui Zhang, et al.
ACS Applied Materials & Interfaces|June 20, 2025
iRGD-NaGd(MoO<sub>4</sub>)<sub>2</sub>: A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING PathwayLing Yu, Fengkai Qiu, Yumin Hu, et al.
Cancer Research|July 4, 2018
<i>PDSS2</i> Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose MetabolismYan Li, Shuhai Lin, Lei Li, et al.
Nature Communications|April 24, 2023
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient seraYao Yao, Xueping Wang, Jian Guan, et al.
Cancer Letters|February 27, 2025
SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancerJunchen Pan, Rui Liu, Wenhua Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndromeGuillermo Garcia-Manero, Francesco Paolo Tambaro, Nebiyou B Bekele, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Theranostics|July 9, 2019
Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modificationTian Tian, Jiajun Li, Yizhuo Li, et al.
Cell Research|August 31, 2011
K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysisYumin Hu, Weiqin Lu, Gang Chen, et al.
Molecular Metabolism|March 6, 2021
Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodelingXin You, Jingyu Tian, Hui Zhang, et al.
ACS Applied Materials & Interfaces|June 20, 2025
iRGD-NaGd(MoO<sub>4</sub>)<sub>2</sub>: A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING PathwayLing Yu, Fengkai Qiu, Yumin Hu, et al.
Cancer Research|July 4, 2018
<i>PDSS2</i> Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose MetabolismYan Li, Shuhai Lin, Lei Li, et al.
Nature Communications|April 24, 2023
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient seraYao Yao, Xueping Wang, Jian Guan, et al.
Cancer Letters|February 27, 2025
SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancerJunchen Pan, Rui Liu, Wenhua Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndromeGuillermo Garcia-Manero, Francesco Paolo Tambaro, Nebiyou B Bekele, et al.
Pageof 10